Doxorubicin in relapsed soft tissue sarcoma: Justification of phase II evaluation of new drugs in this disease: An EORTC soft tissue and bone sarcoma group study
- 28 February 1990
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (2) , 139-141
- https://doi.org/10.1016/0277-5379(90)90296-6
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trialsBritish Journal of Cancer, 1989
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987